Clinical Trial Update: A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports safety and pharmacokinetic results from a Phase 2/3 study of liquid human alpha-1 proteinase inhibitor in alpha-1 antitrypsin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• Liquid Alpha1-Proteinase Inhibitor (Human) (alpha-1 proteinase inhibitor (human))

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Alpha₁-Antitrypsin Deficiency | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-03-13